Morinidazole and Sodium Chloride Injection | China Drugs List

Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.

Company
Jiangsu Hansoh Pharmaceutical
Medicine type
Chemical medicine
Therapeutic area
Infectious diseases
Indications recorded in the public source
For infections caused by susceptible anaerobic bacteria in adults aged 18 years and older: gynecological pelvic inflammatory disease, including endometritis, salpingitis, tubo-ovarian abscess and pelvic peritonitis; and, alongside surgery, suppurative appendicitis and gangrenous appendicitis. For mixed aerobic and anaerobic infections, an antibacterial active against aerobic organisms should also be considered according to the clinical situation. This description is based on the prescribing information for the Chengdu Gowell generic product with the same generic name; the complete originator-brand prescribing information has not yet been obtained.
Indication source and scope
Source date(s): 2025-05-09. Manufacturer prescribing information for Mainland China. Generic label from Chengdu Guowei; not the originator brand.
Prescribing-information limitations
Complete Chinese label obtained for a generic with the same ingredient. The originator brand label remains unavailable.
China availability status
Historical Chinese approval verified; current continuous market availability has not been checked for every product.
Overseas status
Market-by-market verification pending.
Insurance classification
Included in national insurance (Category B)
Insurance edition
2025 edition; effective 1 January 2026
Insurance restrictions
Limited to second-line use.
Insurance verification notes
Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

Sources

Open the interactive record, public price references and discussions